Rockefeller Capital Management
BIIB icon

Rockefeller Capital Management’s Biogen BIIB Stock Holding History

Rockefeller Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.24M Buy
6,761
+1,754
+35% +$323K ﹤0.01% 1514
2025
Q4 		$881K Sell
5,007
-168
-3% -$27.4K ﹤0.01% 1606
2025
Q3 		$725K Buy
+5,175
New +$700K ﹤0.01% 1586
2023
Q3 		– Sell
-8,019
Closed -$2.28M – 1519
2023
Q2 		$2.28M Sell
8,019
-2,337
-23% -$696K 0.01% 803
2023
Q1 		$2.88M Buy
10,356
+3,891
+60% +$1.08M 0.01% 707
2022
Q4 		$1.79M Buy
6,465
+300
+5% +$84.7K 0.01% 790
2022
Q3 		$1.65M Sell
6,165
-192
-3% -$40.8K 0.01% 826
2022
Q2 		$1.29M Sell
6,357
-177
-3% -$36.2K 0.01% 910
2022
Q1 		$1.38M Buy
6,534
+333
+5% +$72.4K 0.01% 949
2021
Q4 		$1.49M Sell
6,201
-7,219
-54% -$1.86M 0.01% 907
2021
Q3 		$3.8M Sell
13,420
-2,151
-14% -$705K 0.02% 556
2021
Q2 		$5.39M Sell
15,571
-3,340
-18% -$1.01M 0.03% 433
2021
Q1 		$5.29M Buy
18,911
+3,942
+26% +$1.06M 0.04% 352
2020
Q4 		$3.66M Sell
14,969
-7,974
-35% -$2.06M 0.03% 379
2020
Q3 		$6.51M Sell
22,943
-1,022
-4% -$285K 0.06% 235
2020
Q2 		$6.41M Sell
23,965
-539
-2% -$162K 0.07% 220
2020
Q1 		$7.75M Buy
24,504
+8,139
+50% +$2.47M 0.1% 182
2019
Q4 		$4.86M Sell
16,365
-4,192
-20% -$1.16M 0.06% 225
2019
Q3 		$4.79M Sell
20,557
-229,540
-92% -$53.4M 0.06% 201
2019
Q2 		$58.5M Sell
250,097
-4,154
-2% -$959K 0.82% 34
2019
Q1 		$60.1M Sell
254,251
-72,747
-22% -$22.9M 0.86% 29
2018
Q4 		$98.4M Buy
326,998
+5,376
+2% +$1.72M 1.72% 17
2018
Q3 		$114M Buy
321,622
+37,049
+13% +$12.8M 1.72% 17
2018
Q2 		$82.6M Sell
284,573
-3,291
-1% -$925K 1.34% 27
2018
Q1 		$78.8M Buy
+287,864
New +$89.4M 1.3% 25

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Rockefeller Capital Management's BIIB Position: Q1 2026 in Review

Rockefeller Capital Management increased its Biogen (BIIB) stake by 35% in Q1 2026, buying an estimated $323K and bringing the position to 6,761 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #1514.

Rockefeller Capital Management first reported a position in BIIB in Q1 2018 and has held it in 25 quarters since. The position peaked at $114M in Q3 2018. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Rockefeller Capital Management held 6,761 shares of Biogen worth $1.24M as of Q1 2026.
  • Rockefeller Capital Management bought 1,754 Biogen shares in Q1 2026, an estimated $323K.
  • Biogen made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #1514 holding.
  • Rockefeller Capital Management first reported a position in Biogen in Q1 2018 and has held it in 25 quarters since.
  • Rockefeller Capital Management's Biogen position peaked at $114M in Q3 2018.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.